Skip to content

Study Comparing One Versus Two Cortisone Injections for Trigger Finger

A Prospective, Randomized Study Comparing One vs. Two Cortisone Injections for Trigger Finger

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00951236
Enrollment
392
Registered
2009-08-04
Start date
2009-05-31
Completion date
Unknown
Last updated
2014-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stenosing Tenosynovitis, Trigger Finger

Keywords

Trigger Finger, Trigger Thumb

Brief summary

Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.

Interventions

DRUGOne cortisone injection

Patients in this arm will receive one cortisone injection for the treatment of his/her symptoms

DRUGTwo cortisone Injections

Subjects randomized to this treatment will receive two cortisone injections, 4-6 weeks apart

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Intervention model
PARALLEL
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is greater than 18 years of age, presenting with stenosing tenosynovitis. * Subject is willing and able to provide informed consent.

Exclusion criteria

* Patients who have previously undergone surgery for the treatment of trigger finger.

Design outcomes

Primary

MeasureTime frame
To determine if there is a difference in the incidence of pain, stiffness, clicking or locking at 6 months following final injection

Secondary

MeasureTime frame
To evaluate treatment response among diabetic patients
To evaluate treatment response between thumbs and fingers
To evaluate treatment response between nodular versus diffuse tenosynovitis

Countries

United States

Contacts

Primary ContactCharles Leinberry, MD
charlie.leinberry@rothmaninstitute.com267-339-3677
Backup ContactTiffany Morrison, MS
tiffany.morrison@rothmaninstitute.com267-339-7818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026